Circle Pharma Gets FDA Orphan Drug Status for CID-078 in SCLC
Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...